Fabrication of poly (lactic-co-glycolic acid)/mesoporous silica composite nanofibers for controllable co-delivery of 5-fluorouracil and curcumin against HT-29 colon cancer cells

[1]  Aylin Ahmadinia,et al.  A pH-sensitive magnetic hydrogel nanocomposite based on alginate for controlled release of methotrexate , 2023, International Journal of Polymeric Materials and Polymeric Biomaterials.

[2]  N. Zarghami,et al.  Stimulus-responsive nanocarrier from star-shaped polyethyleneimine-β-cyclodextrin coated mesoporous silica for targeted combination cancer therapy , 2023, Journal of Drug Delivery Science and Technology.

[3]  B. Hatami,et al.  Oral Targeted Delivery of Imatinib by pH Responsive Copolymer Modulates Liver Fibrosis in the Mice Model. , 2023, International journal of pharmaceutics.

[4]  M. Irani,et al.  Paclitaxel-loaded liposome-incorporated chitosan (core)/poly(ε-caprolactone)/chitosan (shell) nanofibers for the treatment of breast cancer. , 2023, International journal of biological macromolecules.

[5]  N. Zarghami,et al.  Osteogenic differentiation of adipose-derived stem cells on dihydroartemisinin electrospun nanofibers , 2022, Journal of Biological Engineering.

[6]  Z. Mohammadi,et al.  Graphene-MoS2 polyfunctional hybrid hydrogels for the healing of transected Achilles tendon. , 2022, Biomaterials advances.

[7]  N. Zarghami,et al.  Stimulus-responsive drug/gene delivery system based on polyethylenimine cyclodextrin nanoparticles for potential cancer therapy. , 2021, Carbohydrate polymers.

[8]  I. García-Alonso,et al.  Curcumin Reduces Colorectal Cancer Cell Proliferation and Migration and Slows In Vivo Growth of Liver Metastases in Rats , 2021, Biomedicines.

[9]  A. Olad,et al.  The effect of montmorillonite in graphene oxide/chitosan nanocomposite on controlled release of gemcitabine , 2021, Polymer Bulletin.

[10]  Qian Wang,et al.  Targeting laryngeal cancer cells with 5-fluorouracil and curcumin using mesoporous silica nanoparticles , 2020, Technology in cancer research & treatment.

[11]  A. Alshamsan,et al.  The Design of Anionic Surfactant-Based Amino-Functionalized Mesoporous Silica Nanoparticles and their Application in Transdermal Drug Delivery , 2020, Pharmaceutics.

[12]  M. Irani,et al.  Fabrication of poly(acrylic acid) grafted-chitosan/ polyurethane/magnetic MIL-53 metal organic framework composite core-shell nanofibers for co-delivery of temozolomide and paclitaxel against glioblastoma cancer cells. , 2020, International journal of pharmaceutics.

[13]  M. Adeli,et al.  Fabrication of new generation of co-delivery systems based on graphene-g-cyclodextrin/chitosan nanofiber. , 2019, International journal of biological macromolecules.

[14]  Hongbo Zhang,et al.  Electrospun PLGA membrane incorporated with andrographolide-loaded mesoporous silica nanoparticles for sustained antibacterial wound dressing. , 2018, Nanomedicine.

[15]  Z. Tian,et al.  Nanotechnology for Cancer Therapy Based on Chemotherapy , 2018, Molecules.

[16]  Huifen Chen,et al.  Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice , 2017, Journal of Experimental & Clinical Cancer Research.

[17]  E. Alizadeh,et al.  Study of the Cytotoxic and Bactericidal Effects of Sila‐substituted Thioalkyne and Mercapto‐thione Compounds based on 1,2,3‐Triazole Scaffold , 2017, Basic & clinical pharmacology & toxicology.

[18]  Mengqiu Long,et al.  Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery , 2017, Journal of biomaterials applications.

[19]  S. Yaghmaei,et al.  Curcumin-Loaded Amine-Functionalized Mesoporous Silica Nanoparticles Inhibit α-Synuclein Fibrillation and Reduce Its Cytotoxicity-Associated Effects. , 2016, Langmuir : the ACS journal of surfaces and colloids.

[20]  G. Robertson,et al.  Nanotechnology-based strategies for combating toxicity and resistance in melanoma therapy. , 2016, Biotechnology advances.

[21]  K. D. Safa,et al.  Synthesis of novel 1,4-disubstituted 1,2,3-triazoles bearing organosilicon-sulfur groups via the click reaction sonocatalyzed by LaCuxMn1-xO3 nanoparticles , 2016 .

[22]  Xiaoxing Liu,et al.  Preparation, Characterization, and Antitumor Evaluation of Electrospun Resveratrol Loaded Nanofibers , 2016 .

[23]  K. D. Safa,et al.  A simple and efficient synthesis of organosilicon compounds containing 1,2,3-triazole moieties catalyzed by ZSM-5 zeolite-supported Cu–Co bimetallic oxides , 2016, Monatshefte für Chemie - Chemical Monthly.

[24]  Lixin Wei,et al.  Inhibition of Growth and Metastasis of Colon Cancer by Delivering 5-Fluorouracil-loaded Pluronic P85 Copolymer Micelles , 2016, Scientific Reports.

[25]  E. Zemtsova,et al.  Pore radius fine tuning of a silica matrix (MCM-41) based on the synthesis of alumina nanolayers with different thicknesses by atomic layer deposition , 2015 .

[26]  K. Chennazhi,et al.  In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[27]  Seeram Ramakrishna,et al.  Drug delivery vehicles on a nano-engineering perspective. , 2014, Materials science & engineering. C, Materials for biological applications.

[28]  Jin-Zhi Du,et al.  Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy. , 2014, Biotechnology advances.

[29]  Xuesi Chen,et al.  Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer. , 2014, Biomaterials.

[30]  Rachita Lakra,et al.  Curcumin loaded poly (lactic-co-glycolic) acid nanofiber for the treatment of carcinoma. , 2014, Colloids and surfaces. B, Biointerfaces.

[31]  D. He,et al.  In vitro and in vivo evaluation of pectin-based nanoparticles for hepatocellular carcinoma drug chemotherapy. , 2014, Molecular pharmaceutics.

[32]  S. Feng,et al.  Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers. , 2013, Biomaterials.

[33]  A. Yılmaz,et al.  Surface functionalization of SBA-15 particles for amoxicillin delivery , 2012 .

[34]  A. Suksamrarn,et al.  Hexahydrocurcumin enhances inhibitory effect of 5-fluorouracil on HT-29 human colon cancer cells. , 2012, World journal of gastroenterology.

[35]  Jiang Chang,et al.  Dual drug release from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats with distinct release profiles. , 2012, Acta biomaterialia.

[36]  Evzen Amler,et al.  Core/shell nanofibers with embedded liposomes as a drug delivery system. , 2012, Biomacromolecules.

[37]  Christine Vauthier,et al.  HPLC quantification of doxorubicin in plasma and tissues of rats treated with doxorubicin loaded poly(alkylcyanoacrylate) nanoparticles. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[38]  Yang Di,et al.  Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside. , 2011, Cancer treatment reviews.

[39]  Guangjun Nie,et al.  Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. , 2011, Biomaterials.

[40]  Hyoun‐Ee Kim,et al.  Nanostructured poly(epsilon-caprolactone)-silica xerogel fibrous membrane for guided bone regeneration. , 2010, Acta biomaterialia.

[41]  K. Leong,et al.  Electrohydrodynamics: A facile technique to fabricate drug delivery systems. , 2009, Advanced drug delivery reviews.

[42]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.

[43]  A. Rishi,et al.  Curcumin enhances the effects of 5‐fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF‐1R , 2008, International journal of cancer.

[44]  P. Keegan,et al.  FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer. , 2007, The oncologist.

[45]  Liping Jiang,et al.  Synergistic Inhibitory Effects of Curcumin and 5-Fluorouracil on the Growth of the Human Colon Cancer Cell Line HT-29 , 2005, Chemotherapy.

[46]  P. Johnston,et al.  5-Fluorouracil: mechanisms of action and clinical strategies , 2003, Nature Reviews Cancer.

[47]  H. Klotz,et al.  Local and systemic toxicity of intra-hepatic-arterial 5-FU and high-dose or low-dose leucovorin for liver metastases of colorectal cancer. , 1994, Surgical oncology.

[48]  N. Peppas,et al.  Mechanisms of solute release from porous hydrophilic polymers , 1983 .

[49]  T. Higuchi.  MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES. , 1963, Journal of pharmaceutical sciences.

[50]  L. Kong,et al.  Functionalization of hollow mesoporous silica nanoparticles for improved 5-FU loading , 2015 .

[51]  D. Saslow,et al.  Cancer screening in the United States, 2011 , 2011, CA: a cancer journal for clinicians.